%PDF-1.4
%
57 0 obj
<>
endobj
54 0 obj
<>
endobj
115 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-03-01T13:27:59Z
2024-03-28T22:06:29-07:00
QuarkXPressª: AdobePS 8.8.0 (301)
2024-03-28T22:06:29-07:00
application/pdf
Heather
2003-829.april
uuid:6fbbe2c7-1dd2-11b2-0a00-1709275d6100
uuid:6fbbe2c9-1dd2-11b2-0a00-aa0000000000
endstream
endobj
43 0 obj
<>
endobj
44 0 obj
<>
endobj
58 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 29 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 31 0 R/Type/Page>>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 33 0 R/Type/Page>>
endobj
23 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 35 0 R/Type/Page>>
endobj
26 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 37 0 R/Type/Page>>
endobj
133 0 obj
[137 0 R]
endobj
134 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
13.5 787.5 585 -783 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 73.868 737.0293 Tm
(heterogeneity in patients with neonatal-onset multisystem)Tj
0 -1.25 TD
(inflammatory disease \(NOMID\): a new member of the expanding)Tj
T*
[(family of pyrin-associated autoinflammatory diseases. )54.8 (Arthritis)]TJ
0 Tc T*
(Rheum 2002;46:3340-8.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(21.)-875.1 (Sarrauste de Menthiere C, )17.7 (T)69.9 (erriere S, Pugnere D, Ruiz M, Demaille)]TJ
2.175 -1.25 Td
[(J, )17.7 (T)69.9 (ouitou I. INFEVERS: the Registry for FMF and hereditary)]TJ
T*
[(inflammatory disorder mutations. Nucleic )54.8 (Acids Res 2003;)]TJ
0 Tc 0 Tw T*
(31:282-5.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(22.)-875.1 (Dode C, Le Du N, Cuisset L, et al. New mutations of CIAS1 that)]TJ
2.175 -1.25 Td
[(are responsible for Muckle-W)79.7 (ells syndrome and familial cold)]TJ
T*
[(urticaria: a novel mutation underlies both syndromes. )54.8 (Am J Hum)]TJ
T*
(Genet 2002;70:1498-506.)Tj
-2.175 -1.25 Td
[(23.)-875.1 (Granel B, Philip N, Serratrice J, et al. CIAS1 mutation in a patient)]TJ
2.175 -1.25 Td
[(with overlap between Muckle-W)79.8 (ells and chronic infantile)]TJ
T*
(neurological cutaneous and articular syndromes. Dermatology)Tj
0 Tc 0 Tw T*
(2003;206:257-9.)Tj
-0.00011 Tc 0.02499 Tw 30.825 18.75 Td
[(24.)-875.1 (Campadelli-Fiume G, Mirandola P)110.7 (, Menotti L. Human herpesvirus)]TJ
2.175 -1.25 Td
[(6: )54.8 (An emer)17.7 (ging pathogen. Emer)17.7 (g Infect Dis 1999;5:353-66.)]TJ
-2.175 -1.25 Td
[(25.)-875.1 (Kosuge H. HHV)91.7 (-6, 7 and their related diseases. J Dermatol Sci)]TJ
0 Tc 0 Tw 2.175 -1.25 Td
(2000;22:205-12.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(26.)-875.1 (Mizukawa )36.8 (Y)128.9 (, Shiohara )17.7 (T)74 (.)-0.1 ( )17.7 (V)59.8 (irus-induced immune dysregulation as a)]TJ
2.175 -1.25 Td
(triggering factor for the development of drug rashes and)Tj
T*
(autoimmune diseases: with emphasis on EB virus, human)Tj
T*
(herpesvirus 6 and hepatitis C virus. J Dermatol Sci 2000;22:169-80.)Tj
-2.175 -1.25 Td
[(27.)-875.1 (T)69.9 (oyabe S, Harada )17.7 (W)91.9 (, Suzuki H, Hirokawa )17.7 (T)74 (, Uchiyama M. Lar)17.7 (ge)]TJ
2.175 -1.25 Td
(vessel arteritis associated with human herpesvirus 6 infections. Clin)Tj
T*
(Rheumatol 2002;21:528-32.)Tj
-2.175 -1.25 Td
[(28.)-875.1 (W)39.8 (iersbitzky S, Ratzmann GW)91.7 (, Bruns R, )17.7 (W)39.9 (iersbitzky H.)]TJ
2.175 -1.25 Td
(Reactivation in children of juvenile chronic arthritis and chronic)Tj
T*
(iridocyclitis associated with human herpesvirus-6 infection. Padiatr)Tj
T*
(Grenzgeb 1993;31:203-5.)Tj
ET
0 0 0 1 K
53.468 76.5 m
558.468 76.5 l
S
0 0 0 0 k
494.29 69.365 64.178 -15.665 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
0 Tc 0 Tw 8 0 0 8 545.468 56.4344 Tm
(751)Tj
ET
0 0 0 0 k
53.532 70.507 203 -16.521 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 54.532 56.7204 Tm
(Hentgen, et al: CIAS1 mutation)Tj
ET
0 0 0 0 k
/GS0 gs
103.631 80.583 407.5 -10.833 re
f*
0.5 w
/GS1 gs
103.631 80.583 407.5 -10.833 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_2 8 Tf
108.828 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
37 0 obj
<>stream
8;Z\t!=j`9$j6J.&*>qe?0i9T_Gl(5D8&T+dGVNK8qd!hJF1cSjNr@EL+_itq/7f"
ms!.\gB6_B1<)b?1%m"a(SGB9!Vsl#ZDau43V,pW-aW\8epsU#qWI-1>Jeh6esK=&
*2,Y!&WC,fqi0Hjoi7p+4tEEW;\Q,l\ZDiXY&B*CL8^6@$=$1\0'B!IC6tg[^p`>b
.;+ou50%]ooNh+W7&n;!YBXsnB3?B^_;53^@iEK
endstream
endobj
41 0 obj
[/Indexed/DeviceRGB 255 40 0 R]
endobj
40 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
66 0 obj
<>
endobj
67 0 obj
<>
endobj
104 0 obj
<>
endobj
120 0 obj
<>
endobj
68 0 obj
<>
endobj
99 0 obj
<>stream
H|yPWǻgqiۀ"\%cjDaБcaGp l,V
B%^51[5ak|T6dTn_z~ۿ}I0ǧ-
Y3'B1,OVkח*LpDž
.vpv98Q2idݞ(1Ս͝.
%ev'&xbt;5c&/Otu&f'pQcHW'y5lPhԆ8^˯&34|@NyWgb1eQUsvb1\æH0'sfLc;lǶXñaKE'1)F`oq_)Y ɒtHJHy
+bN#k{[o&Nol'e9HEP-JO;\Hlz^*q:W
4%ne/B(uŜ7Z&6"6m/
@g2dK
HGf" T A*[(TvIߐ`0iZMԨ|ߓ|-3PDL\13/`.rCZv:nϟa CD
KKeG2Q헝RkSS^~)/?^*@\BAGΒuO[
Jbrn6-rSXNdX*xG4%-Wr" 0-fh3ȥn`kg;]kC
0\@GD+hU'$Av[IJGC\!Nro,0-jjD=Je+RQxN~)ߋ]@
0,
? fR$f7nS$l۰Ӏ97pT`ާ!a'Otѧ?6\ܫͷU` cұ_'FuJ[ٻ3G`>Pa)OFhF$kY0sSCԍa3ij!1W~3Cx+}AC"aKSBiTAѠCL<#\6lc`D#4fc
gY';;ڂVĻ#K?3т$LCC>3^U2)"" RS1U XZk:} Z#0AP`0i)2C1MIL=#J*b,3>I-qT'`#NS_ ~ejKte;M=BnahI'$r.p∼֭[z
pB+ffOEn@Pq&RP xr+~Fވۊ/U[@9L*ࠥbK7H*ܨו}'1?͚|7}l[8PYv1VG.DY%m*aMP*sj(#KNTA+fjB `^SFRwĮLdXǕɨ=ٜV}f"/mX&8(Ec3ò̑nr>TԝҮzܖ~rffv4ਧpj|y~N=Wg`'DnD*W\d
e GP
͜tˬ"-C
Mx.!
<#FW&n &jKG?4kxsb2~8i
?ɢ&Vn"Y/xp7nk\jq{QzH$D~#'Xe_{Ce;4hJcSh/8XTlD2&$=^Yּl|Uԙ'{3cI{{qh;.2iVE@ͅEBBaN$절Q0ZuD2ZK
t~<>"N̤p ~/]nC(%yU0.Nj"dlӟK
efyd"EU'5E#T
Rʮ
rŦ4ZV`A{6FZ$$@FZU`
2,"